Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Advertise in Pharma in Focus

Advertising in Pharma in Focus delivers you:

  • Unique access to a $17 billion industry
  • High visibility with over 11,500 readers every working day
  • Great reaction with high click through rates
  • Unparalled contact via unique beyond-the-click services

For more information, ring 02 9938 4381

Approvals Action
First generic for LSDP drug
Inborn error of metabolism treatment copied.
Pipeline Monitor
Keytruda scores ninth use
Cervical cancer and PBMC lymphoma join lengthening indication line.
MA makes obvious CEO choice
But new leader will face the same challenges as her predecessors.